Research and Markets: Singapore's Burgeoning Biomedical Science Sector Fuels Growth in the Pharmaceuticals and Life Sciences IT Market

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/9566a8/singaporean_pharma) has
announced the addition of Frost & Sullivan's new report "Singaporean
Pharmaceuticals and Life Sciences IT Market" to their offering.

This research service provides the latest update on the pharmaceuticals and life
sciences IT Market in Singapore, as well as, the competitive market landscape in
terms of major participants and future trends. The research service identifies
the market opportunities and evolving trends that will influence market entry,
expansion and domination in years to come.

Singapore's Burgeoning Biomedical Science Sector Fuels Growth in the
Pharmaceuticals and Life Sciences IT Market

Bolstered by a vibrant biomedical manufacturing sector, Singapore's
pharmaceutical and life sciences sector is in its growth phase and steadily
moving towards maturity. Singapore has emerged as a technological and
manufacturing hotspot with top pharmaceutical and life sciences companies
operating on its shores. The fast pace of development of the biomedical science
industry has boosted the country's manufacturing output, enabling its
positioning as the biomedical hub of Asia. "Opportunities to provide integration
services or mid-market enterprise and production systems abound in niche areas,"
notes the analyst of this research service. "Software-as-a-service (SaaS) based
customer resource management (CRM), enterprise resource planning (ERP) and
software configuring management (SCM) applications are anticipated to see higher
uptake among MNC pharmaceutical and life sciences companies as they apply an
incremental approach to upgrade their client server technology tools in sales
and marketing."

Small and medium businesses (SMBs) in Singapore are expected to step up spending
and allocate a large proportion of their resources for networking, storage, and
security. ERP and e-businesses are gaining traction in this sector as smaller
enterprises strive hard to optimize productivity, and reduce workforces by
automating essential function. Multinational and large local pharmaceutical
companies are the forerunners in IT adoption. Evidence points to a movement
toward early adoption of well integrated enterprise applications with readiness
for data mining tools for information extraction. There is a distinct preference
for incremental IT solutions, which can be easily interfaced with existing
systems to provide data analysis techniques. IT firms are patronizing IT systems
more than their life science counterparts as they are larger and have more
spending power.

Streamlined Regulatory Practices and Prolific R&D Activities Steer the Market
Forward

"Scientists and large pharmaceutical firms need a strong level of confidence
that their inventions will be protected before the volume of research activities
grow in Singapore," says the analyst. "The new Health Products Act 2007 should
improve regulatory practice for both medical devices and pharmaceuticals."
Amendments to the Medicines Act have been made to provide greater protection for
pharmaceuticals patents. The prominent sectors engaged in research currently are
the government and universities. Funds are apportioned for the promotion of
spin-off activities and the commercialization of indigenously developed new
technologies. As the competition heats up among research labs to commercialize
their new inventions, the pressure builds up on product lead times. In such a
scenario, strong support in computing will provide the critical competitive
edge. Developing improved operational and managerial processes and the use of
advanced technology would greatly help compress R&D time.

Key Topics Covered:

1. Executive Summary

2. Research Overview

3. Total Market Analysis

4. End-user Analysis

5. Competitive Landscape

6. Decision Support Databases

For more information visit
http://www.researchandmarkets.com/research/9566a8/singaporean_pharma

Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716

Copyright Business Wire 2009